mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.097 |
0.02 |